Samarzija recently found that Hedgehog (Hh) signaling pathway is activated in cervical cancer-derived cells by using Shh ligand and Hh pathway inhibitors, indicating inhibition of this pathway may be a therapeutic option to fight cervical cancer [21]. This evidence concerns the gene SHH and cervical carcinoma.